Comparing techniques for drug loading of shape-memory polymer networks - effect on their functionalities

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 1, 2010, Pages 136-147

  Wischke, Christian ^a,b   Neffe, Axel T ^a   Steuer, Susi ^c   Lendlein, Andreas ^a,b  

^a INSTITUTE OF MATERIALS RESEARCH   (Germany)

^b Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^c Intervet Innovation GmbH   (Germany)

Author keywords

Biomaterial; Controlled drug release; Degradable polymers; Polymer network; Shape memory polymer

Indexed keywords

ETHACRIDINE LACTATE; METHACRYLIC ACID DERIVATIVE; OLIGO[(EPSILON CAPROLACTONE) CO GLYCOLIDE]DIMETHACRYLATE; POLYMER; UNCLASSIFIED DRUG; SOLUTION AND SOLUBILITY;

ARTICLE; BODY TEMPERATURE; CROSS LINKING; DRUG DEGRADATION; DRUG DISTRIBUTION; DRUG HYDROLYSIS; DRUG RELEASE; DRUG SOLUTION; DRUG SYNTHESIS; HYDROPHILICITY; INTERMETHOD COMPARISON; MOLECULAR WEIGHT; PRIORITY JOURNAL; CHEMISTRY; COMPARATIVE STUDY; SOLUTION AND SOLUBILITY;

POLYMERS; SOLUTIONS;

EID: 77954758483     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.06.003     Document Type: Article

References (36)

1. Baer G.M., Small W., Wilson T.S., Benett W.J., Matthews D.L., Hartman J., Maitland D.J. Fabrication and in vitro deployment of a laser-activated shape memory polymer vascular stent. Biomed. Eng. Online 2007, 6:8.
2. Behl M., Lendlein A. Actively moving polymers. Soft Matter 2007, 3:58-67.
3. Behl M., Zotzmann J., Lendlein A. Shape-memory polymers and shape-changing polymers. Adv. Polym. Sci. 2010, 226:1-40.
4. Binzen E., Lendlein A., Kelch S., Rickert D., Franke R.P. Biomaterial-microvasculature interaction on polymers after implantation in mice. Clin. Hemorheol. Microcirc. 2004, 30:283-288.
5. Choi N.Y., Lendlein A. Degradable shape-memory polymer networks from oligo[(L-lactide)-ran-glycolide]dimethacrylates. Soft Matter 2007, 3:901-909.
6. Corrigan O.I., Li X. Quantifying drug release from PLGA nanoparticulates. Eur. J. Pharm. Sci. 2009, 37:477-485.
7. Feng Y.K., Behl M., Kelch S., Lendlein A. Biodegradable multiblock copolymers based on oligodepsipeptides with shape-memory properties. Macromol. Biosci. 2009, 9:45-54.
8. Gall K., Dunn M.L., Liu Y.P., Finch D., Lake M., Munshi N.A. Shape memory polymer nanocomposites. Acta Mater. 2002, 50:5115-5126.
9. Gall K., Yakacki C.M., Liu Y.P., Shandas R., Willett N., Anseth K.S. Thermomechanics of the shape memory effect in polymers for biomedical applications. J. Biomed. Mater. Res. A 2005, 73A:339-348.
10. Grablowitz H., Lendlein A. Synthesis and characterization of alpha,omega-dihydroxy-telechelic oligo(p-dioxanone). J. Mater. Chem. 2007, 17:4050-4056.
11. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 1961, 50:874-875.
12. Hill V.L., Paserini N., Craig D.Q.M., Vickers M., Anwar J., Feely L.C. Investigation of progesterone loaded poly(d,l-lactide) microspheres using TMDCS, SEM and PXRD. J. Therm. Anal. 1998, 54:673-685.
13. Holland S.J., Tighe B.J., Gould P.L. Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems. J. Control. Release 1986, 4:155-180.
14. Kelch S., Choi N.Y., Wang Z.G., Lendlein A. Amorphous, elastic AB copolymer networks from acrylates and poly[(l-lactide)-ran-glycolide]dimethacrylates. Adv. Eng. Mater. 2008, 10:494-502.
15. Kelch S., Steuer S., Schmidt A.M., Lendlein A. Shape-memory polymer networks from oligo[(epsilon-hydroxycaproate)-co-glycolate]dimethacrylates and butyl acrylate with adjustable hydrolytic degradation rate. Biomacromolecules 2007, 8:1018-1027.
16. Langer R., Siegel R., Brown L., Leong K., Kost J., Edelman E. Controlled release and magnetically modulated systems for macromolecular drugs. Ann. N. Y. Acad. Sci. 1985, 446:1-13.
17. Lendlein A., Behl M., Hiebl B., Wischke C. Shape-memory polymers as a technology platform for biomedical applications. Expert. Rev. Med. Device 2010, 7:357-379.
18. Lendlein A., Colussi M., Neuenschwander P., Suter U.W. Hydrolytic degradation of phase-segregated multiblock copoly(ester urethane)s containing weak links. Macromol. Chem. Phys. 2001, 202:2702-2711.
19. Lendlein A., Kelch S. Degradable, multifunctional polymeric biomaterials with shape-memory. Mater. Sci. Forum 2005, 492-493:219-223.
20. Lendlein A., Langer R. Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 2002, 296:1673-1676.
21. Lendlein A., Neuenschwander P., Suter U.W. Tissue-compatible multiblock copolymers for medical applications, controllable in degradation rate and mechanical properties. Macromol. Chem. Phys. 1998, 199:2785-2796.
22. Lendlein A., Neuenschwander P., Suter U.W. Hydroxy-telechelic copolyesters with well defined sequence structure through ring-opening polymerization. Macromol. Chem. Phys. 2000, 201:1067-1076.
23. Manias E. Nanocomposites - Stiffer by design. Nat. Mater. 2007, 6:9-11.
24. Nagahama K., Ueda Y., Ouchi T., Ohya Y. Biodegradable shape-memory polymers exhibiting sharp thermal transitions and controlled drug release. Biomacromolecules 2009, 10:1789-1794.
25. Neffe A.T., Hanh B.D., Steuer S., Lendlein A. Polymer networks combining controlled drug release, biodegradation, and shape memory capability. Adv. Mater. 2009, 21:3394-3398.
26. Neffe A.T., Hanh B.D., Steuer S., Wischke C., Lendlein A. Thermomechanical properties and shape-memory capability of drug loaded semi-crystalline polyestermethacrylate networks. Mater. Res. Soc. Symp. Proc. 2009, 1190:105-111.
27. Neffe A.T., Tronci G., Alteheld A., Lendlein A. Controlled change of mechanical properties during hydrolytic degradation of polyester urethane networks. Macromol. Chem. Phys. 2010, 211:182-194.
28. Park T.G. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials 1995, 16:1123-1130.
29. Pitt C.G., Gratzl M.M., Jeffcoat A.R., Zweidinger R., Schindler A. Sustained drug delivery systems. 2. Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. J. Pharm. Sci. 1979, 68:1534-1538.
30. Rickert D., Lendlein A., Schmidt A.M., Kelch S., Roehlke W., Fuhrmann R., Franke R.P. In vitro cytotoxicity testing of AB-polymer networks based on oligo(epsilon-caprolactone) segments after different sterilization techniques. J. Biomed. Mater. Res. B 2003, 67B:722-731.
31. Sharp A.A., Panchawagh H.V., Ortega A., Artale R., Richardson-Burns S., Finch D.S., Gall K., Mahajan R.L., Restrepo D. Toward a self-deploying shape memory polymer neuronal electrode. J. Neural Eng. 2006, 3:L23-30.
32. Wada R., Hyon S.H., Nakamura T., Ikada Y. In vitro evaluation of sustained drug release from biodegradable elastomer. Pharm. Res. 1991, 8:1292-1296.
33. Wischke C., Lendlein A. Shape-memory polymers as drug carriers-A multifunctional system. Pharm. Res. 2010, 27:527-529.
34. Wischke C., Neffe A.T., Lendlein A. Controlled drug release from shape-memory polymers. Adv. Polym. Sci. 2010, 226:177-205.
35. Wischke C., Neffe A.T., Steuer S., Lendlein A. Evaluation of a degradable shape-memory polymer network as matrix for controlled drug release. J. Control. Release 2009, 138:243-250.
36. Wykrzykowska J.J., Onuma Y., Serruys P.W. Advances in stent drug delivery: the future is in bioabsorbable stents. Expert. Opin. Drug Deliv. 2009, 6:113-126.